Aurinia Pharmaceuticals Gets European Commission Approval Of Lupkynis For The The Treatment Of Adults With Active Lupus Nephritis
https://ec.europa.eu/transparency/documents-register/detail?ref=C(2022)6734&lang=en
Alnylam/Regeneron-Backed NASH Candidate Shows Encouraging Safety Profile In Healthy Volunteers
Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced preliminary Phase 1 data supporting the clinical advancement of ALN-HSD for nonalcoholic steatohepatitis…
Tenax Therapeutics Stock Jumps On Strategic Alternative Review
Tenax Therapeutics Inc (NASDAQ:TENX) is evaluating alternative strategic paths. Roth Capital Partners will support Tenax Therapeutics as its financial advisor…
Pfizer’s Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents
Pfizer Inc (NYSE:PFE) has announced topline results from the Phase 3 trial of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy…
Processa Pharmaceuticals Provides Update On Enrollment Across All Clinical Programs
PCS12852 for Gastroparesis concluded enrollment a month ahead of schedule. Statistics on gastric emptying, safety and GEBT data will be available by the end of October and full topline data is expected before year
Celsion Completes Enrollment Of The Phase I/II OVATION 2 Study With GEN-1 In Advanced Ovarian Cancer
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone
LAWRENCEVILLE, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celsion
Top Financial Media Stories Thursday, September 15: US Railway Companies, Unions Reach Tentative Agreement, Tesla To Wind Down Stores In China’s Flashy Malls, Netflix Could Face Legal Action Over South Korean Crime Drama And More..
US Railway Companies, Unions Reach Tentative Agreement Averting Catastrophic Strike
Jasper Therapeutics Announces FDA Fast Track Designation For JSP191
JSP191 is currently being evaluated in four ongoing clinical studies in allogeneic hematopoietic stem cell transplant in patients with Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS), SCID, Fanconi
Important Biotech Catalysts For September 14, 2022 – End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON)…
Eloxx Shares Plummet As Mid-Stage Cystic Fibrosis Study Results Miss Efficacy Endpoints
Eloxx Pharmaceuticals (NASDAQ: ELOX) announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation.